Geode Capital Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.2M Sell
1,642,552
-20,749
-1% -$255K ﹤0.01% 1954
2025
Q1
$36.6M Buy
1,663,301
+86,643
+5% +$1.91M ﹤0.01% 1560
2024
Q4
$35.8M Sell
1,576,658
-247,336
-14% -$5.61M ﹤0.01% 1644
2024
Q3
$33.1M Sell
1,823,994
-3,854
-0.2% -$70K ﹤0.01% 1694
2024
Q2
$53.3M Buy
1,827,848
+507,380
+38% +$14.8M ﹤0.01% 1318
2024
Q1
$46.8M Buy
1,320,468
+64,360
+5% +$2.28M ﹤0.01% 1404
2023
Q4
$54.7M Sell
1,256,108
-6,080
-0.5% -$265K 0.01% 1287
2023
Q3
$48.2M Buy
1,262,188
+137,942
+12% +$5.27M 0.01% 1254
2023
Q2
$46.2M Buy
1,124,246
+24,637
+2% +$1.01M 0.01% 1309
2023
Q1
$63.1M Buy
1,099,609
+37,020
+3% +$2.13M 0.01% 1015
2022
Q4
$59.6M Buy
1,062,589
+54,238
+5% +$3.04M 0.01% 1034
2022
Q3
$42.7M Buy
1,008,351
+12,086
+1% +$512K 0.01% 1190
2022
Q2
$53.8M Sell
996,265
-17,613
-2% -$952K 0.01% 1058
2022
Q1
$65.2M Buy
1,013,878
+7,431
+0.7% +$478K 0.01% 1063
2021
Q4
$67.4M Buy
1,006,447
+57,231
+6% +$3.83M 0.01% 1080
2021
Q3
$65M Buy
949,216
+5,609
+0.6% +$384K 0.01% 1054
2021
Q2
$64.4M Buy
943,607
+18,937
+2% +$1.29M 0.01% 1096
2021
Q1
$63.9M Buy
924,670
+22,369
+2% +$1.55M 0.01% 1034
2020
Q4
$58.6M Buy
902,301
+47,555
+6% +$3.09M 0.01% 994
2020
Q3
$40.4M Sell
854,746
-34,498
-4% -$1.63M 0.01% 1032
2020
Q2
$41.8M Buy
889,244
+8,038
+0.9% +$378K 0.01% 992
2020
Q1
$39.4M Buy
881,206
+35,667
+4% +$1.59M 0.01% 888
2019
Q4
$49.3M Buy
845,539
+13,464
+2% +$785K 0.01% 942
2019
Q3
$50M Buy
832,075
+4,033
+0.5% +$242K 0.01% 883
2019
Q2
$46.2M Buy
828,042
+57,910
+8% +$3.23M 0.01% 911
2019
Q1
$42.9M Buy
770,132
+38,701
+5% +$2.16M 0.01% 921
2018
Q4
$33M Buy
731,431
+39,637
+6% +$1.79M 0.01% 955
2018
Q3
$45.6M Buy
691,794
+23,155
+3% +$1.53M 0.01% 853
2018
Q2
$43.1M Buy
668,639
+75,589
+13% +$4.87M 0.01% 851
2018
Q1
$32.8M Buy
593,050
+29,653
+5% +$1.64M 0.01% 948
2017
Q4
$27M Buy
563,397
+2,579
+0.5% +$123K 0.01% 1055
2017
Q3
$28.3M Buy
560,818
+28,262
+5% +$1.43M 0.01% 994
2017
Q2
$29M Buy
532,556
+824
+0.2% +$44.9K 0.01% 942
2017
Q1
$22.4M Buy
531,732
+33,742
+7% +$1.42M 0.01% 1055
2016
Q4
$21.4M Buy
497,990
+55,166
+12% +$2.37M 0.01% 1041
2016
Q3
$18.3M Buy
442,824
+32,250
+8% +$1.33M 0.01% 1062
2016
Q2
$16.4M Buy
410,574
+4,278
+1% +$171K 0.01% 1079
2016
Q1
$13.7K Buy
406,296
+14,540
+4% +$490 0.01% 1157
2015
Q4
$13.3M Buy
391,756
+34,608
+10% +$1.17M 0.01% 1160
2015
Q3
$10.6M Sell
357,148
-37,947
-10% -$1.13M 0.01% 1302
2015
Q2
$10.9M Buy
395,095
+10,857
+3% +$299K 0.01% 1354
2015
Q1
$9.68M Buy
384,238
+19,322
+5% +$487K 0.01% 1408
2014
Q4
$8.09M Buy
364,916
+32,722
+10% +$725K ﹤0.01% 1498
2014
Q3
$6.74M Buy
332,194
+1,842
+0.6% +$37.4K ﹤0.01% 1569
2014
Q2
$6.35M Buy
330,352
+25,473
+8% +$490K ﹤0.01% 1638
2014
Q1
$5.73M Buy
304,879
+10,324
+4% +$194K ﹤0.01% 1675
2013
Q4
$5.74M Buy
294,555
+30,246
+11% +$590K ﹤0.01% 1595
2013
Q3
$4.35M Buy
264,309
+2,681
+1% +$44.1K ﹤0.01% 1659
2013
Q2
$3.92M Buy
+261,628
New +$3.92M ﹤0.01% 1594